{"abstract":null,"action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/02/25/2013-04141.html","cfr_references":[],"citation":"78 FR 12762","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket No. FDA-2013-N-0001"],"dockets":[],"document_number":"2013-04141","effective_on":null,"end_page":12763,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/02/25/2013-04141.xml","html_url":"https://www.federalregister.gov/documents/2013/02/25/2013-04141/joint-meeting-of-the-medical-imaging-drugs-advisory-committee-and-the-oncologic-drugs-advisory","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-04141?publication_date=2013-02-25","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-02-25/2013-04141/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":221,"last_updated":"2026-09-22 16:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-02-25/pdf/2013-04141.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-04141.pdf?1361553005","publication_date":"2013-02-25","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/02/25/2013-04141.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Transcripts Great Workshop II - Day 2 - FINAL","document_id":"FDA-2013-N-0001-0131"},{"title":"Transcripts Great Workshop II - Day 1 - FINAL","document_id":"FDA-2013-N-0001-0130"},{"title":"FDA ICCR Public Meeting  (May 8 2013) Transcript","document_id":"FDA-2013-N-0001-0129"}],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2013-N-0001","supporting_documents_count":3,"docket_id":"FDA-2013-N-0001","regulation_id_number":null,"title":"Advisory Committee, Workshops, and Conferences Notices Various Meeting Notices (eg., Task Force Meeting, etc)","checked_regulationsdotgov_at":"2013-03-17T06:00:12Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":12762,"subtype":null,"title":"Joint Meeting of the Medical Imaging Drugs Advisory Committee and the Oncologic Drugs Advisory Committee; Notice of Meeting.","toc_doc":"Medical Imaging Drugs Advisory Committee and Oncologic Drugs Advisory Committee","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":78}